Bacterial vulvovaginitis (Trichomonas vaginalis). Trichomonal vulvovaginitis
Conditions
Interventions
Intervention 1: Intervention group: patients with bacterial vulvovaginitis treated with topical thymol vaginal cream 5 mg, every night for up to one week. Intervention 2: Control group: Patients with
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Female Married Patients with bacterial vulvovaginitis based on ASMEL criteria Willingness to participate in the study and complete the ethical consent form
Exclusion criteria
Exclusion criteria: Irritation or allergic reaction to the drug Aggravation of symptoms caused by infection Not taking medicine for more than one day Women who are pregnant, breastfeeding, have immune deficiency or malignancy History of mental disorders and psychosis Allergic reactions following consumption of thymol or products containing thymol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complaints and clinical observations. Timepoint: Evaluation of complaints and clinical observations on days 1, 3 and 7 days after starting the use of thymol vaginal cream. Method of measurement: Likert scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical observations and complaints. Timepoint: At the beginning of the study and after days 1, 3 and 7 days after starting to use the vaginal cream. Method of measurement: Likert scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Zabihi
Yazd University of Medical Sciences
Outcome results
None listed